Skip to content

Ayurvedic treatment of Amaja Abhishyanda(Acute infective Conjunctivitis) with Punarnavadi eyedrop and Shigrupatradi eyedrop

Efficacy of Punarnavadi eyedrop and Shigrupatradi eyedrop in the management of Amaja Abhishyanda(Acute infective Conjunctivitis)- An Open Labelled Randomised Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/081100
Enrollment
60
Registered
2025-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H102- Other acute conjunctivitis

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda,Jamnagar,Gujarat-361008
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between 18 to 50 years of age with irrespective of Gender,Occupation,Religion,Socio-economic status. Patients having minimum two clinical symptoms of Amaja Abhishyanda. Symptoms developed within less than 5 days.

Exclusion criteria

Exclusion criteria: Patients having complication of Corneal involvementlike Marginal cornral ulcer,Dacrocystitis,Trachoma,Keratoconjunctivitis sicca,Vernal keratoconjunctivitis,Giant papillary Conjunctivitis, Atopic keratoconjunctivitis,Ptergyium. Patient with the complaint of Recurrent allergic conjunctivtis. Uncontrolled systemic disease condition i.e. Diabetes Mellitus,Hypertension,Hepatomegaly. Pregnant and lactating mother should be excluded.

Design outcomes

Primary

MeasureTime frame
Pacification in the clinical features of Amaja Abhishyanda.Timepoint: It will be assessed after 2 weeks.

Secondary

MeasureTime frame
Recurrence of signs and symptoms of Amaja Abhishyanda(Acute infective conjunctivits)Timepoint: 21st & 30th day

Countries

India

Contacts

Public ContactNachita

Institute of Teaching and Research in Ayurveda Jamnagar, Gujrat

drpawar29@itra.edu.in7737379173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026